| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Dec 19, 2025 | Savara Inc | Director | Sell | 32.5 | -20,000 | -0.78% | ✗ | $121.2K |
| Mar 31, 2025 | Apr 1, 2025 | Savara Inc | Director | Buy | 92.5 | +150,000 | 6.35% | ✗ | $416.3K |
| Nov 18, 2024 | Nov 18, 2024 | Savara Inc | Director | Buy | 90.0 | +100,000 | 4.50% | ✗ | $287.6K |
| May 24, 2023 | May 26, 2023 | Savara Inc | Director | Buy | 90.0 | +100,000 | 4.76% | ✗ | $258.5K |
| Dec 29, 2022 | Jan 3, 2023 | Savara Inc | Director | Buy | 82.5 | +36,000 | 1.74% | ✗ | $55.6K |
| Dec 23, 2022 | Dec 28, 2022 | Savara Inc | Director | Buy | 68.8 | +19,000 | 0.93% | ✗ | $27.6K |
| Dec 20, 2022 | Dec 22, 2022 | Savara Inc | Director | Buy | 82.5 | +45,000 | 2.25% | ✗ | $66.4K |
| Dec 16, 2022 | Dec 20, 2022 | Savara Inc | Director | Buy | 87.5 | +54,890 | 2.82% | ✗ | $82.1K |
| Nov 22, 2022 | Nov 25, 2022 | Savara Inc | Director | Buy | 78.8 | +20,105 | 1.04% | ✗ | $28.7K |
| Nov 17, 2022 | Nov 21, 2022 | Savara Inc | Director | Buy | 87.5 | +50,005 | 2.67% | ✗ | $68.4K |
| Sep 23, 2022 | Sep 27, 2022 | Savara Inc | Director | Buy | 90.0 | +135,000 | 7.75% | ✗ | $187.1K |
| Sep 16, 2022 | Sep 20, 2022 | Savara Inc | Director | Buy | 61.3 | +8,000 | 0.46% | ✗ | $11.6K |
| Sep 6, 2022 | Sep 8, 2022 | Savara Inc | Director | Buy | 78.8 | +32,000 | 1.88% | ✗ | $44.7K |
| Aug 30, 2022 | Sep 1, 2022 | Savara Inc | Director | Buy | 90.0 | +100,000 | 6.25% | ✗ | $141.9K |
| Jun 17, 2022 | Jun 22, 2022 | Savara Inc | Director | Buy | 90.0 | +100,000 | 6.66% | ✗ | $138.4K |
| Dec 29, 2021 | Dec 30, 2021 | Savara Inc | Director | Buy | 87.5 | +50,000 | 3.45% | ✗ | $64K |
| Dec 15, 2021 | Dec 17, 2021 | Savara Inc | Director | Buy | 83.8 | +40,000 | 2.83% | ✗ | $44.5K |
| Dec 10, 2021 | Dec 13, 2021 | Savara Inc | Director | Buy | 83.8 | +35,000 | 2.54% | ✗ | $36.4K |
| Dec 7, 2021 | Dec 9, 2021 | Savara Inc | Director | Buy | 78.8 | +25,000 | 1.85% | ✗ | $26.2K |
| Dec 1, 2021 | Dec 2, 2021 | Savara Inc | Director | Buy | 78.8 | +25,000 | 1.89% | ✗ | $27.1K |
| Nov 30, 2021 | Dec 1, 2021 | Savara Inc | Director | Buy | 78.8 | +25,000 | 1.92% | ✗ | $27.2K |
| Nov 18, 2021 | Nov 22, 2021 | Savara Inc | Director | Buy | 95.0 | +200,000 | 18.16% | ✗ | $215.4K |
| Sep 28, 2021 | Sep 30, 2021 | Savara Inc | Director | Buy | 95.0 | +137,052 | 14.22% | ✗ | $176.4K |
| Aug 17, 2021 | Aug 19, 2021 | Savara Inc | Director | Buy | 95.0 | +97,290 | 11.22% | ✗ | $115.2K |
| May 19, 2021 | May 20, 2021 | Savara Inc | Director | Buy | 67.5 | +5,003 | 0.58% | ✗ | $7.9K |
| May 18, 2021 | May 18, 2021 | Savara Inc | Director | Buy | 90.0 | +50,000 | 6.16% | ✗ | $81.1K |
| Mar 15, 2021 | Mar 15, 2021 | Savara Inc | Director | Buy | 97.5 | +689,655 | 564.63% | ✗ | $1000K |
| Jun 26, 2019 | Jun 28, 2019 | Savara Inc | Director | Buy | 95.0 | +58,357 | 91.49% | ✗ | $138.2K |
| Apr 27, 2017 | Jun 19, 2019 | Savara Inc | Director | Buy | 95.0 | +40,215 | 170.62% | ✗ | $95.4K |
| Jun 7, 2017 | Jun 9, 2017 | Savara Inc | Director | Buy | 95.0 | +21,000 | 1470.59% | ✗ | $99.8K |
| Feb 6, 2015 | Feb 6, 2015 | HALOZYME THERAPEUTICS, INC. | CFO | Sell | 48.8 | -2,660 | -0.72% | ✗ | $36.9K |
| Dec 22, 2014 | Dec 22, 2014 | HALOZYME THERAPEUTICS, INC. | CFO | Sell | 42.5 | -6,621 | -1.83% | ✗ | $62.6K |
| Sep 16, 2014 | Sep 16, 2014 | HALOZYME THERAPEUTICS, INC. | CFO | Buy | 90.0 | +25,000 | 8.38% | ✗ | $222.5K |
| May 14, 2012 | May 14, 2012 | Savara Inc | Director | Buy | 91.3 | +50,000 | 100.00% | ✗ | $27K |
| May 9, 2012 | May 10, 2012 | Savara Inc | Director | Buy | 91.3 | +50,000 | 100.00% | ✗ | $28.1K |